These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31468555)

  • 1. Factors influencing caspofungin plasma concentrations in kidney transplant patients with high incidence of invasive fungal infections.
    Yang Q; Zhang T; Zhao D; Zhang Y; Dong Y; Sun D; Du Q; Zheng J; Lu H; Dong Y
    J Clin Pharm Ther; 2020 Feb; 45(1):72-80. PubMed ID: 31468555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
    Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
    Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.
    Fortún J; Muriel A; Martín-Dávila P; Montejo M; Len O; Torre-Cisneros J; Carratalá J; Muñoz P; Fariñas C; Moreno A; Fresco G; Goikoetxea J; Gavaldá J; Pozo JC; Bodro M; Vena A; Casafont F; Cervera C; Silva JT; Aguado JM;
    Liver Transpl; 2016 Apr; 22(4):427-35. PubMed ID: 26709146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis.
    Baker AW; Maziarz EK; Arnold CJ; Johnson MD; Workman AD; Reynolds JM; Perfect JR; Alexander BD
    Clin Infect Dis; 2020 Jan; 70(1):30-39. PubMed ID: 30801642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
    J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients.
    Veroux M; Macarone M; Fiamingo P; Cappello D; Gagliano M; Di Mare M; Vizcarra D; Spataro M; Giuffrida G; Sorbello M; Severino V; Veroux P
    Transplant Proc; 2006 May; 38(4):1037-9. PubMed ID: 16757256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.
    Maximova N; Schillani G; Simeone R; Maestro A; Zanon D
    Adv Ther; 2017 May; 34(5):1184-1199. PubMed ID: 28429246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation.
    Groetzner J; Kaczmarek I; Wittwer T; Strauch J; Meiser B; Wahlers T; Daebritz S; Reichart B
    J Heart Lung Transplant; 2008 Jan; 27(1):1-6. PubMed ID: 18187079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of anidulafungin in solid organ transplant recipients].
    Aguado JM; Ayats J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():29-34. PubMed ID: 19572432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis.
    Gatti M; Rinaldi M; Ferraro G; Toschi A; Caroccia N; Arbizzani F; Raschi E; Poluzzi E; Pea F; Viale P; Giannella M
    Mycoses; 2021 Nov; 64(11):1317-1327. PubMed ID: 34387004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
    Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
    J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
    Pepeler MS; Yildiz Ş; Yegin ZA; Özkurt ZN; Tunçcan ÖG; Erbaş G; Köktürk N; Kalkanci A; Yildirim Z
    J Infect Dev Ctries; 2018 Sep; 12(9):799-805. PubMed ID: 31999640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Antifungal Prophylaxis in Lung Transplant Recipients.
    Pennington KM; Dykhoff HJ; Yao X; Sangaralingham LR; Shah ND; Peters SG; Barreto JN; Razonable RR; Kennedy CC
    Ann Am Thorac Soc; 2021 Mar; 18(3):468-476. PubMed ID: 32962402
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients.
    Florea NR; Capitano B; Nightingale CH; Hull D; Leitz GJ; Nicolau DP
    Transplant Proc; 2003 Dec; 35(8):2873-7. PubMed ID: 14697925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function tests while on caspofungin.
    Doria C; Bodzin AS; Vaccino S; Daskalakis C; Krawitz S; Ramirez CB
    Clin Transplant; 2011; 25(4):569-75. PubMed ID: 20662881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive fungal infection after heart transplantation: A 7-year, single-center experience.
    Echenique IA; Angarone MP; Gordon RA; Rich J; Anderson AS; McGee EC; Abicht TO; Kang J; Stosor V
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Posaconazole Serum Concentrations from Delayed-Release Tablets in Patients at High Risk for Fungal Infections.
    Chin A; Pergam SA; Fredricks DN; Hoofnagle AN; Baker KK; Jain R
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for early invasive fungal infections in paediatric liver transplant recipients.
    Pasternak Y; Rubin S; Bilavsky E; Mozer-Glassberg Y; Levy I; Nahum E; Rom E; Gurevich M; Ben-Zvi H; Ashkenazi-Hoffnung L
    Mycoses; 2018 Sep; 61(9):639-645. PubMed ID: 29663565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal infections in lung transplantation.
    Samanta P; Clancy CJ; Nguyen MH
    J Thorac Dis; 2021 Nov; 13(11):6695-6707. PubMed ID: 34992845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.